Even as the delta variant increases COVID-19 case numbers in the U.S., distributors and manufacturers are reporting they had too much PPE in the second quarter.
After years of negotiations, several major drug distributors have proposed a settlement to resolve claims they contributed to the opioid crisis.
The CBP’s final rule is seen as aiding the U.S. Postal Service in weighing which shipments fail to comply with a data preclearance directive.
Random testing increase to 50% expected to boost clearinghouse activity.
Legislation demands OMB and HHS estimate rule publication date.
There isn’t a driver shortage. In fact, there is a glut of capacity on the road, and not enough freight to haul.
White House receives guidelines but DOT, FMCSA still must sign off.
Hair follicle testing – once cleared for use in the federal database – could have the biggest effect on driver availability.
